External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

AUS Winter 2026

We will be contributing to topics related to
-
03:27 PM
Duration 9mins Park City, USA
Vamikibart in Patients With Uveitic Macular Edema in the Phase 3 MEERKAT and SANDCAT Trials: Durability of Response 8 Weeks After the Last Per-Protocol Injection
Brian Do
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon